{"disease":{"id":"aicardi-goutieres-syndrome","name":"aicardi goutieres syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT03921554","title":"JAK Inhibitor Treatment in AGS","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Adeline Vanderver, MD","has_results":true},{"nct_id":"NCT04517253","title":"A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Eli Lilly and Company","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}